6533b828fe1ef96bd1288c96

RESEARCH PRODUCT

The Role of Erythropoietin in Aneurysmal Subarachnoid Haemorrhage: From Bench to Bedside

Filippo GiambartinoGiovanni GrassoMichele Buemi

subject

medicine.medical_specialtySubarachnoid hemorrhagebusiness.industryVasospasmmedicine.diseaseBench to bedsidenervous system diseasesAneurysmErythropoietinInternal medicinemedicineCardiologySubarachnoid haemorrhagecardiovascular diseasesbusinessNimodipinemedicine.drugCause of death

description

Subarachnoid haemorrhage (SAH) caused by a ruptured aneurysm accounts for only 5 % of strokes, but occurs at a fairly young age and carries a poor prognosis. Delayed cerebral ischaemia (DCI) is an important cause of death and dependence after aneurysmal SAH. The current mainstay of preventing DCI is nimodipine and maintenance of normovolemia, but even with this strategy DCI occurs in a considerable proportion of patients.

yearjournalcountryeditionlanguage
2014-08-02
https://doi.org/10.1007/978-3-319-04981-6_13